Episil-Precision, Inc. AI Stock Analysis
Episil-Precision, Inc. (3016) AI Stock Analysis
Episil-Precision, Inc.
(TWSE:3016)
Episil-Precision scores poorly overall, driven primarily by severely eroded earnings power: three consecutive years of revenue decline, operating margin near breakeven at 0.3%, and return on equity of just 0.4%. A conservative balance sheet (0.23x debt-to-equity, 72% equity-funded assets) and solid depreciation-driven operating cash flow provide downside support, but free cash flow of NT$43m leaves little room for reinvestment or dividends. Technicals compound the picture, with the share price below all major moving averages and a deeply negative MACD, though oversold readings hint at scope for a near-term bounce. Valuation offers no cushion, with a P/E of 54.3 on trough earnings and a slim 0.51% yield. A recovery in fab utilization and pricing is the key catalyst required to improve the outlook.
Episil-Precision, Inc. (3016) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 35.78B
- Dividend Yield
- 0.42%
- Average Volume (3M)
- 11.40M
- Price to Earnings (P/E)
- 62.2
- Beta (1Y)
- 1.85
- Revenue Growth
- 29.78%
- EPS Growth
- 22824.42%
- Country
- TW
- Employees
- 148
- Sector
- General
- Sector Strength
- 55
- Industry
- Semiconductors
Episil-Precision, Inc. Business Overview & Revenue Model
Company Description
Episil-Precision Inc. (3016.TW) specializes in the full lifecycle of advanced epitaxial wafers, from their initial design and development through manufacturing and global distribution. These wafers utilize silicon (Si), silicon carbide (SiC), and gal...
Episil-Precision, Inc. Financial Statement Overview
Summary
Financial results reflect a deep semiconductor downcycle. Revenue has contracted three years running from the NT$5.90bn 2022 peak to NT$3.89bn, while gross margin compressed to 7.9% and operating margin to just 0.3%, leaving net income at a nominal NT$20m (0.5% net margin) and return on equity near zero at 0.4% — the income statement is the clear weak spot (score 29). The balance sheet is the offsetting strength (score 68): debt-to-equity of 0.23 and equity funding roughly 72% of assets give the company staying power, though capital productivity is poor. Cash flow (score 55) is better than headline profit, with NT$492m of operating cash flow driven by heavy depreciation, but capex absorbs nearly all of it, leaving free cash flow at only NT$43m after two years of negative FCF.
Income Statement
29NegativeBalance Sheet
68PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.41B | 3.89B | 4.11B | 4.24B | 5.90B | 5.04B |
| Gross Profit | 696.90M | 306.50M | 382.00M | 495.47M | 1.10B | 726.43M |
| EBITDA | 805.32M | 413.48M | 774.27M | 737.28M | 1.33B | 963.35M |
| Net Income | 348.56M | 20.42M | 264.61M | 164.04M | 681.27M | 380.53M |
Balance Sheet | ||||||
| Total Assets | 7.56B | 6.90B | 7.41B | 6.81B | 7.67B | 6.61B |
| Cash, Cash Equivalents and Short-Term Investments | 2.73B | 2.29B | 2.65B | 2.28B | 2.84B | 1.96B |
| Total Debt | 1.16B | 1.13B | 1.39B | 990.94M | 915.29M | 754.51M |
| Total Liabilities | 2.35B | 1.96B | 2.35B | 1.91B | 2.37B | 2.00B |
| Stockholders Equity | 5.21B | 4.94B | 5.06B | 4.90B | 5.30B | 4.61B |
Cash Flow | ||||||
| Free Cash Flow | 416.35M | 43.15M | -22.42M | -60.67M | 681.98M | 515.95M |
| Operating Cash Flow | 749.66M | 492.48M | 804.97M | 553.67M | 1.16B | 692.46M |
| Investing Cash Flow | -333.47M | -439.41M | -573.25M | -611.84M | -19.09M | -576.52M |
| Financing Cash Flow | 152.12M | -404.80M | 122.77M | -498.41M | 150.19M | 66.51M |
Episil-Precision, Inc. Peers Comparison
Overall Rating
TW:813165Neutral
TW:802857Neutral
TW:232956Neutral
TW:499154Neutral
TW:301644Neutral
TW:370738Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | TWD 23.84B | 13.29 | ― | 1.86% | 37.20% | 416.69% | |
| 57Neutral | TWD 37.35B | 35.55 | ― | 1.33% | 24.28% | 51.82% | |
| 56Neutral | TWD 24.47B | 14.80 | ― | 2.68% | 10.61% | 51.02% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | TWD 42.26B | 78.98 | ― | ― | 52.19% | ― | |
| 44Neutral | TWD 34.46B | 62.18 | ― | 0.42% | 29.78% | 22824.42% | |
| 38Underperform | TWD 24.11B | -51.01 | ― | ― | 22.70% | 38.31% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:3016 | Episil-Precision, Inc. | 117.50 | 65.19 | 124.61% | |
| TW:2329 | Orient Semiconductor Electronics, Limited | 37.30 | -14.60 | -28.13% | |
| TW:3707 | Episil Technologies Inc. | 60.20 | 9.80 | 19.44% | |
| TW:4991 | GCS Holdings, Inc. | 352.00 | 186.17 | 112.27% | |
| TW:8028 | Phoenix Silicon International Corp. | 203.50 | 43.93 | 27.53% | |
| TW:8131 | Formosa Advanced Technologies Co., Ltd. | 53.90 | 6.24 | 13.10% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
